GLP1R and thyroid gland carcinoma: A 2025 meta-analysis by Silverii et al. that pooled 50 randomized trials, GLP-1 RA were associated with a modest but significant increase in thyroid cancer risk (MH-OR 1.55, 95% CI 1.05–2.27), particularly in longer-duration studies.